GlassScriptPhysician profile
Daniel Austin Cox
NPI 1376056234
$10,537.14
in general payments reported to CMS, 2019-2025
47 companies · $2,128 in 2025
The $2,128 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,620 · 2022: $1,358 · 2023: $2,916 · 2024: $2,515 · 2025: $2,128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,291 · Education: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,291.03 |
| Education | $268.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $2,114.79 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $1,617.72 | 2021-2024 | Myrbetriq, Xtandi, Veozah |
| Janssen Biotech, INC. | $861.55 | 2021-2025 | Erleada, Akeega, Rybrevant |
| Abbvie INC. | $725.51 | 2021-2025 | |
| Antares Pharma, INC. | $502.21 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Urogen Pharma, INC. | $405.77 | 2021-2024 | Jelmyto |
| Pfizer INC. | $335.28 | 2022-2025 | |
| Verity Pharmaceuticals INC. | $331.13 | 2023-2025 | Trelstar, Tlando |
| Myovant Sciences INC. | $326.80 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $237.47 | 2021-2025 | |
| Progenics Pharmaceuticals, INC. | $220.89 | 2022-2025 | Pylarify |
| Boston Scientific Corporation | $192.94 | 2022-2025 | Axonics, Spaceoar Vue System - 10ml |
| Olympus America INC. | $183.56 | 2024-2025 | Itind System |
| Urovant Sciences INC | $182.26 | 2022 | |
| Medtronic, INC. | $166.81 | 2022-2023 | Interstim |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $165.75 | 2024 | Axonics |
| Accord Healthcare, INC. | $153.97 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $141.61 | 2021-2025 | Provenge |
| Tolmar Pharmaceuticals, INC. | $138.36 | 2021-2022 | |
| Tolmar, INC. | $137.41 | 2023-2025 | Jatenzo |
| Endo USA, INC. | $111.55 | 2025 | Xiaflex, Aveed |
| Halozyme INC | $111.40 | 2023 | |
| Dentsply Ih Ab | $100.34 | 2021-2024 | Lofric |
| Immunitybio, INC. | $97.89 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $97.54 | 2021-2023 | Aveed, Xiaflex |
| Merck Sharp & Dohme LLC | $90.21 | 2023-2024 | Keytruda, Welireg, Lynparza |
| Teleflex LLC | $90.17 | 2024-2025 | Urolift, Barrigel |
| Convatec INC. | $85.99 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $65.66 | 2025 | |
| Edap Technomed INC | $63.00 | 2024 | |
| Telix Pharmaceuticals | $62.93 | 2022-2024 | Illuccix |
| Blue Earth Diagnostics | $52.20 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $49.39 | 2025 | Azmiro |
| Vertex Pharmaceuticals Incorporated | $39.27 | 2025 | |
| Procept Biorobotics Corporation | $32.45 | 2022-2023 | Aquabeam Robotic System |
| Coloplast Corp | $30.48 | 2023-2024 | Speedicath |
| Bluewind Medical | $23.73 | 2024 | Revi |
| Ferring Pharmaceuticals INC. | $23.32 | 2024 | Firmagon |
| Advanced Sterilization Products Services INC. | $23.31 | 2024 | 100nx |
| Ambu INC. | $23.06 | 2025 | |
| Laborie Medical Technologies Corp. | $21.59 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Clarus Therapeutics INC. | $20.33 | 2021 | |
| Alexion Pharmaceuticals, INC. | $19.26 | 2021 | |
| Hollister Incorporated | $17.93 | 2023 | Infyna Chic, Onli, Vapro Plus Pocket |
| Agiliti Surgical, INC. | $16.49 | 2023 | Trinity, Sonablate |
| Sagent Pharmaceuticals | $12.98 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.